Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Teva targets $4 billion lupus market with laquinimod study
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Antibodies to potassium channels in multiple sclerosis.
The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
Gain of glycosylation: A new pathomechanism of myelin protein zero mutations.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
Inflammation high-field magnetic resonance imaging.
Fingolimod Therapy and Macular Hemorrhage.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
Multiple sclerosis: Progression rate and severity in a multicenter cohort from Algeria.
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
A Standardized, Evidence-Based Massage Therapy Program for Decentralized Elite Paracyclists: Creating the Model.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Persistence of Epstein-Barr Virus in Self-reactive Memory B Cells.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.
Pages
« first
‹ previous
…
229
230
231
232
233
234
235
236
237
…
next ›
last »